Project: A 3D-culture platform for in-vitro preclinical Screening of Immunotherapies.
| Acronym | 3D-SCREEN (Reference Number: 113869) |
| Duration | 01/06/2020 - 01/12/2023 |
| Project Topic | This consortium will revolutionize in-vitro preclinical screening of novel immunotherapy candidates by delivering a 3D-tumour culturing platform (3D-SCREEN) that combines latest advances in co-culturing of cancer and immune cells. By leveraging high-throughput 3D-culturing and imaging, along with a comprehensive profiling of expressed proteins and immune cell populations, 3D-SCREEN allows a functional screen of immunotherapy efficacy combined with mechanistic insights for the observed effect. |
| Network | Eurostars 2 |
| Call | Eurostars Cut–off 12 |
Project partner
| Number | Name | Role | Country |
|---|---|---|---|
| 1 | AnaPath Services GmbH | Partner | Switzerland |
| 2 | Crown Bioscience Netherlands B.V. | Partner | Netherlands |
| 3 | Sciomics GmbH | Coordinator | Germany |
| 4 | University of Basel | Partner | Switzerland |
| 5 | VitroScan B.V. | Partner | Netherlands |